Do some reading around pseudoprogression mate.
Some did stop treatment due, it was thought, to adverse tumour enlargement early on after treatment.
Imu have subsequently established increase in tumour size was due to pseudoprogression. We are absolutely at the cutting edge here, evaluating as we go.
Once you get your head around the various ways our products target and impact cancer, you will probably feel a lot better about your investment.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-13617
-
- There are more pages in this discussion • 1,052 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
5.7¢ | 5.7¢ | 5.7¢ | $61.22K | 1.074M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 1700145 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1228069 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11337 | 0.085 |
1 | 51572 | 0.062 |
1 | 13052 | 0.058 |
11 | 896939 | 0.057 |
15 | 1593428 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 100000 | 1 |
0.056 | 468001 | 4 |
0.057 | 1228070 | 2 |
0.058 | 100863 | 2 |
0.059 | 466527 | 6 |
Last trade - 10.04am 16/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online